MECHELEN, BELGIUM--(Marketwire - January 16, 2008) - Galapagos NV (Euronext & LSE: GLPG) announces today that it has been awarded a EUR 4.4 M grant from the Flanders government through the Institute for the Promotion of Innovation by Science and Technology (IWT). The three-year project entitled “Kinases in Inflammation” aims to accelerate Galapagos’ rheumatoid arthritis (RA) programs through clinical Proof of Concept in man.
